[Changes in the management of cardiac arrest].
NEW RECOMMENDATIONS: for cardio-pulmonary resuscitation Methods such as mouth to mouth or the search for a pulse, until now the fundamental preliminaries, have now become second line. Everything must be organised to allow for defibrillation as rapidly as possible. NEW MODALITIES FOR CARDIAC MASSAGE: The frequency of compressions recommended is currently 100 per minute in the adult with a rhythm of compression-ventilation reaching 15/2 before intubation. Concerning the haemodynamic agents for cardiac arrest, the efficacy of high doses of adrenalin is not greater than with conventional doses. Vasopressin is not superior to intravenous adrenalin regarding survival at 24 hrs exepet in case of asystoly. Dopamine at a "renal" dose is no longer used. ANTIARRYTHMICS: Amiodarone is part of the decisional tree in the case of ventricular fibrillation or ventricular tachycardia without a pulse. Semi-automatic defibrillator accessibility should be generalized. INFUSED SOLUTIONS: Sodium bicarbonate does not improve the survival except in particular cases. Physiological serum should be preferred to glucosed serum during reanimation.
Genest
Marc
M
Service de cardiologie, Centre hospitalier, Provins. marc.genest@wanadoo.fr
Pochmalicki
Gilbert
G
D000328:Adult; D000359:Aftercare / Q000379:methods / Q000639:trends; D000465:Algorithms; D000638:Amiodarone / Q000627:therapeutic use; D016887:Cardiopulmonary Resuscitation / Q000379:methods / Q000592:standards / Q000639:trends; D002317:Cardiovascular Agents / Q000494:pharmacology / Q000600:supply & distribution / Q000627:therapeutic use; D003663:Decision Trees; D004554:Electric Countershock / Q000295:instrumentation / Q000379:methods / Q000639:trends; D004562:Electrocardiography; D004837:Epinephrine / Q000627:therapeutic use; D005440:Fluid Therapy / Q000379:methods / Q000639:trends; D005602:France; D006323:Heart Arrest / Q000175:diagnosis / Q000209:etiology / Q000401:mortality / Q000503:physiopathology / Q000628:therapy*; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D010808:Physical Examination / Q000379:methods / Q000639:trends; D017410:Practice Guidelines as Topic; D012121:Respiration, Artificial; D017693:Sodium Bicarbonate / Q000627:therapeutic use; D016019:Survival Analysis; D016896:Treatment Outcome; D014481:United States; D014667:Vasopressins / Q000627:therapeutic use
D002317:Cardiovascular Agents; D014667:Vasopressins; D017693:Sodium Bicarbonate; D000638:Amiodarone; D004837:Epinephrine